Carlo Fremd

856 total citations
25 papers, 455 citations indexed

About

Carlo Fremd is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carlo Fremd has authored 25 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carlo Fremd's work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Carlo Fremd is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Carlo Fremd collaborates with scholars based in Germany, United States and Switzerland. Carlo Fremd's co-authors include Andreas Schneeweiß, Christoph Domschke, Florian Schuetz, Christof Sohn, Philipp Beckhove, Katharina Smetanay, Markus Wallwiener, Matthias C. Klotz, Sebastian I. Wolf and Dirk Jäger and has published in prestigious journals such as Cancer Research, Journal of Bone and Joint Surgery and Annals of Oncology.

In The Last Decade

Carlo Fremd

23 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlo Fremd Germany	12	264	131	115	100	69	25	455
Aaron M. Muscarella United States	6	355 1.3×	73 0.6×	105 0.9×	146 1.5×	71 1.0×	9	454
Jenny Down United Kingdom	10	126 0.5×	73 0.6×	38 0.3×	133 1.3×	58 0.8×	15	320
Elizabeth M. Chislock United States	6	197 0.7×	75 0.6×	39 0.3×	248 2.5×	41 0.6×	6	469
Yawen Ju United States	12	237 0.9×	93 0.7×	42 0.4×	205 2.0×	34 0.5×	21	510
Qiongdan Zheng China	10	235 0.9×	89 0.7×	135 1.2×	255 2.5×	46 0.7×	11	641
Sophie Thiolloy United States	7	192 0.7×	33 0.3×	168 1.5×	197 2.0×	22 0.3×	12	421
Luana Lamura Italy	7	221 0.8×	34 0.3×	58 0.5×	127 1.3×	49 0.7×	12	333
Bo He China	13	288 1.1×	316 2.4×	167 1.5×	349 3.5×	55 0.8×	14	731
Bogang Wu United States	10	190 0.7×	98 0.7×	46 0.4×	126 1.3×	37 0.5×	22	379
J. Carlos Trindade Filho United States	3	247 0.9×	77 0.6×	126 1.1×	138 1.4×	80 1.2×	4	360

Countries citing papers authored by Carlo Fremd

Since Specialization

Citations

This map shows the geographic impact of Carlo Fremd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Fremd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Fremd more than expected).

Fields of papers citing papers by Carlo Fremd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Fremd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Fremd. The network helps show where Carlo Fremd may publish in the future.

Co-authorship network of co-authors of Carlo Fremd

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Fremd. A scholar is included among the top collaborators of Carlo Fremd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Fremd. Carlo Fremd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roberti, María Paula, Pornpimol Charoentong, Stefan B. Eichmüller, et al.. (2025). Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site. OncoImmunology. 14(1). 2457793–2457793. 1 indexed citations

Michel, Laura L., Dániel Schwarz, Manuel Feißt, et al.. (2025). Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy. JAMA Oncology. 11(4). 408–408. 8 indexed citations

Clemente, Hugo, Katharina Smetanay, Carlo Fremd, et al.. (2024). HER2(-Low) Expression on Circulating Tumor Cells and Corresponding Metastatic Tissue in Metastatic Breast Cancer. Oncology Research and Treatment. 48(4). 161–173. 1 indexed citations

Böhm, H., et al.. (2024). Systematic profiling of primary invasive lobular breast carcinoma defines distinct candidates for PD-1/PD-L1 targeting immunotherapy. European Journal of Cancer. 200. 113833–113833.

Deutsch, Thomas M., Chris Sidey‐Gibbons, Fabian Riedel, et al.. (2024). Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic Treatment. JCO Clinical Cancer Informatics. 8(8). e2400010–e2400010. 2 indexed citations

Fremd, Carlo, et al.. (2023). Non-Response of Epstein–Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases. Pathogens. 12(12). 1387–1387.

Meixner, Eva, Philipp Hoegen, Fabian Weykamp, et al.. (2023). Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer. Technology in Cancer Research & Treatment. 22. 2223906425–2223906425. 5 indexed citations

Fischer, Stefanie, Thorsten Oliver Götze, Aurelius Omlin, et al.. (2022). A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer After Prior Trastuzumab and Pertuzumab. JCO Precision Oncology. 6(6). e2200006–e2200006. 5 indexed citations

Deutsch, Thomas M., Manuel Feißt, Fabian Riedel, et al.. (2022). Abstract P2-12-08: Impact of summation dose intensity product on pathologic response in patients receiving neoadjuvant chemotherapy for early breast cancer. Cancer Research. 82(4_Supplement). P2–12. 1 indexed citations

10.

Michel, Laura L., Manuel Feißt, Michael O. Breckwoldt, et al.. (2022). 1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial. Annals of Oncology. 33. S1257–S1258. 3 indexed citations

11.

Deutsch, Thomas M., Manuel Feißt, Fabian Riedel, et al.. (2022). Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer. Archives of Gynecology and Obstetrics. 306(3). 875–885. 12 indexed citations

12.

Meixner, Eva, Philipp Hoegen, Laila König, et al.. (2022). Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer. Technology in Cancer Research & Treatment. 21. 2213860076–2213860076. 1 indexed citations

13.

Deutsch, Thomas M., Sabine Riethdorf, Carlo Fremd, et al.. (2020). HER2-targeted therapy influences CTC status in metastatic breast cancer. Breast Cancer Research and Treatment. 182(1). 127–136. 30 indexed citations

14.

Deutsch, Thomas M., Juliane Nees, Florian Schütz, et al.. (2020). Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer. Breast Cancer Research and Treatment. 183(1). 137–144. 28 indexed citations

15.

Deutsch, Thomas M., Stefan Stefanović, Manuel Feißt, et al.. (2020). Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer. Cancers. 12(4). 1055–1055. 22 indexed citations

16.

Neuendorff, Nina Rosa, Lukas P. Frenzel, Florian Leuschner, & Carlo Fremd. (2020). Integrating clonal haematopoiesis into geriatric oncology: The ARCH between aging, cardiovascular disease and malignancy. Journal of Geriatric Oncology. 12(3). 479–482. 3 indexed citations

17.

Fremd, Carlo, Mario Hlevnjak, Marc Zapatka, et al.. (2018). Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient. Breast Care. 14(1). 53–59. 15 indexed citations

18.

Riedel, Fabian, Carlo Fremd, Patrik Tabatabai, et al.. (2016). Exam preparation course in obstetrics and gynecology for the German Medical State Examination: proof of concept and implications for the recruitment of future residents. Archives of Gynecology and Obstetrics. 294(6). 1235–1241. 4 indexed citations

19.

Fremd, Carlo, Stefan Stefanović, Philipp Beckhove, et al.. (2015). Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients. OncoImmunology. 5(1). e1057387–e1057387. 40 indexed citations

20.

Dreher, Thomas, Sebastian I. Wolf, Daniel Heitzmann, et al.. (2014). Tibialis Posterior Tendon Transfer Corrects the Foot Drop Component of Cavovarus Foot Deformity in Charcot-Marie-Tooth Disease. Journal of Bone and Joint Surgery. 96(6). 456–462. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact